Recent Advances in Amyloidosis: A Disease You Can't Afford to Miss

Date/Time: Tuesday, October 6, 2020 - 12:00 PM – 1:15 PM
Track: Interactive Workshop
Log in to Add to My Schedule


Amyloidosis represents a heterogeneous group of disorders that may present with a diverse spectrum of clinical manifestations.  In recent years there have been great advances in our understanding of the pathogenesis of this complex condition.  This has led to an increase in the ability to provide more directed care, including novel, molecular-based therapeutic approaches.  In this session and hear from leading experts as they discuss the latest advances in the pathogenesis, clinical care and features of amyloidosis, ranging from its effects on the cerebrovascular system to peripheral neuropathy.  This along with data from ongoing clinical trials will provide the attendee with the most up to date evidence for this complex disorder.  


  • To better understand the clinical features and diagnosis of amyloid neuropathy.

  • To learn recent advances on the pathogenesis and clinical care of cerebral amyloid angiopathy.

  • To learn about recently approved molecular therapies for TTR-related amyloidosis and ongoing clinical trials.


Amyloid Polyneuropathy

Cerebral Amyloid Angiopathy

New and Emerging Therapies for Amyloidosis